MAP1LC3A and Wilson disease: Additionally, GDFMD administration suppressed autophagy in the liver of WD mouse models, as evidenced by reduced formation of autophagosomes and improved expression of autophagy-related proteins, such as p62, Beclin-1, and LC3.